CUMBERLAND PHARMACEUTICALS INC Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Cumberland Pharmaceuticals Inc quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Cumberland Pharmaceuticals Inc Debt-to-equity for the quarter ending September 30, 2024 was 196 %, a 32.6% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 196 +48 +32.6% Sep 30, 2024
Q2 2024 177 +32.2 +22.2% Jun 30, 2024
Q1 2024 162 +19.2 +13.4% Mar 31, 2024
Q4 2023 151 +10.9 +7.75% Dec 31, 2023
Q3 2023 147 +22 +17.5% Sep 30, 2023
Q2 2023 145 +32 +28.4% Jun 30, 2023
Q1 2023 143 +42.5 +42.3% Mar 31, 2023
Q4 2022 140 +48.2 +52.3% Dec 31, 2022
Q3 2022 125 +31.2 +33.1% Sep 30, 2022
Q2 2022 113 +15.3 +15.7% Jun 30, 2022
Q1 2022 101 -0.91 -0.9% Mar 31, 2022
Q4 2021 92.3 -8.35 -8.3% Dec 31, 2021
Q3 2021 94.3 -6.15 -6.12% Sep 30, 2021
Q2 2021 97.6 -2.92 -2.91% Jun 30, 2021
Q1 2021 102 +1.46 +1.46% Mar 31, 2021
Q4 2020 101 -2.44 -2.37% Dec 31, 2020
Q3 2020 100 -2.03 -1.98% Sep 30, 2020
Q2 2020 100 +11.1 +12.4% Jun 30, 2020
Q1 2020 100 +23 +29.8% Mar 31, 2020
Q4 2019 103 +40.2 +64.1% Dec 31, 2019
Q3 2019 102 +53.3 +108% Sep 30, 2019
Q2 2019 89.4 +43.2 +93.3% Jun 30, 2019
Q1 2019 77.1 +35.7 +86.4% Mar 31, 2019
Q4 2018 62.8 +27.1 +76% Dec 31, 2018
Q3 2018 49.2 +18 +57.5% Sep 30, 2018
Q2 2018 46.3 +19.1 +70.3% Jun 30, 2018
Q1 2018 41.4 +17.6 +73.8% Mar 31, 2018
Q4 2017 35.7 +14.1 +65% Dec 31, 2017
Q3 2017 31.3 +11.6 +59.2% Sep 30, 2017
Q2 2017 27.2 +8.43 +45% Jun 30, 2017
Q1 2017 23.8 +5.09 +27.2% Mar 31, 2017
Q4 2016 21.6 +3.48 +19.2% Dec 31, 2016
Q3 2016 19.6 +1.87 +10.5% Sep 30, 2016
Q2 2016 18.7 +1.63 +9.53% Jun 30, 2016
Q1 2016 18.7 +2.17 +13.1% Mar 31, 2016
Q4 2015 18.1 +1.81 +11.1% Dec 31, 2015
Q3 2015 17.8 +3.35 +23.2% Sep 30, 2015
Q2 2015 17.1 +3.33 +24.2% Jun 30, 2015
Q1 2015 16.5 +2.88 +21.1% Mar 31, 2015
Q4 2014 16.3 +2.59 +18.9% Dec 31, 2014
Q3 2014 14.4 -0.46 -3.09% Sep 30, 2014
Q2 2014 13.8 -1.77 -11.4% Jun 30, 2014
Q1 2014 13.7 -1.77 -11.5% Mar 31, 2014
Q4 2013 13.7 -1.67 -10.8% Dec 31, 2013
Q3 2013 14.9 -0.55 -3.57% Sep 30, 2013
Q2 2013 15.6 +0.42 +2.78% Jun 30, 2013
Q1 2013 15.4 -0.1 -0.65% Mar 31, 2013
Q4 2012 15.4 Dec 31, 2012
Q3 2012 15.4 Sep 30, 2012
Q2 2012 15.1 Jun 30, 2012
Q1 2012 15.5 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.